XILIO THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.18 USD | +12.38% |
|
+8.26% | +114.55% |
| 04-19 | Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says | MT |
| 04-01 | Xilio Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 1.530 | 2.500 | 1.263 |
| Spread/Res. | -22.88% | -52.80% | -6.57% |
| Spread/Supp. | +28.26% | +135.81% | +121.80% |
| Support | 0.9200 | 0.5004 | 0.5320 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- XLO Stock
- Charts Xilio Therapeutics, Inc.
